{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T20:17:27Z","timestamp":1792786647327,"version":"4.5.0"},"reference-count":55,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2018,7,1]],"date-time":"2018-07-01T00:00:00Z","timestamp":1530403200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2018,7,1]],"date-time":"2018-07-01T00:00:00Z","timestamp":1530403200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2019,5,24]],"date-time":"2019-05-24T00:00:00Z","timestamp":1558656000000},"content-version":"am","delay-in-days":327,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/501100000024","name":"Canadian Institutes of Health Research","doi-asserted-by":"publisher","award":["361828"],"award-info":[{"award-number":["361828"]}],"id":[{"id":"10.13039\/501100000024","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000024","name":"Canadian Institutes of Health Research","doi-asserted-by":"publisher","award":["377975"],"award-info":[{"award-number":["377975"]}],"id":[{"id":"10.13039\/501100000024","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Curing Kids Cancer Foundation","id":[{"id":"https:\/\/ror.org\/0567zyg14","id-type":"ROR","asserted-by":"crossref"}]},{"name":"Brainchild"},{"name":"Meagan's Walk"},{"name":"Laurie Berman"},{"name":"Rob Keyes and Wiley Funds for Brain Tumour Research","id":[{"id":"https:\/\/ror.org\/018kx8h28","id-type":"ROR","asserted-by":"crossref"}]},{"name":"The Cure Starts Now"},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["R01- EB003268"],"award-info":[{"award-number":["R01- EB003268"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Controlled Release"],"published-print":{"date-parts":[[2018,7]]},"DOI":"10.1016\/j.jconrel.2018.05.005","type":"journal-article","created":{"date-parts":[[2018,5,16]],"date-time":"2018-05-16T19:01:14Z","timestamp":1526497274000},"page":"29-41","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":143,"special_numbering":"C","title":["Brainstem blood brain barrier disruption using focused ultrasound: A demonstration of feasibility and enhanced doxorubicin delivery"],"prefix":"10.1016","volume":"281","author":[{"given":"Saira","family":"Alli","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carlyn A.","family":"Figueiredo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brian","family":"Golbourn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nesrin","family":"Sabha","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Megan Yijun","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrew","family":"Bondoc","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amanda","family":"Luck","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0260-5834","authenticated-orcid":false,"given":"Daniel","family":"Coluccia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Colin","family":"Maslink","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christian","family":"Smith","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Heiko","family":"Wurdak","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kullervo","family":"Hynynen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Meaghan","family":"O'Reilly","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"James T.","family":"Rutka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jconrel.2018.05.005_bb0005","first-page":"1","article-title":"Current management of brainstem gliomas","volume":"3","author":"Jallo","year":"2003","journal-title":"Ann. Neurosurg."},{"key":"10.1016\/j.jconrel.2018.05.005_bb0010","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1007\/s003810050542","article-title":"Chemotherapy for brain stem gliomas","volume":"15","author":"Freeman","year":"1999","journal-title":"Childs Nerv. Syst."},{"key":"10.1016\/j.jconrel.2018.05.005_bb0015","doi-asserted-by":"crossref","first-page":"1266","DOI":"10.1200\/JCO.2005.04.6599","article-title":"Advances toward an understanding of brainstem gliomas","volume":"24","author":"Donaldson","year":"2006","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.jconrel.2018.05.005_bb0020","series-title":"Diffuse Intrinsic Pontine Gliomas: Treatments and Controversies","author":"Bredlau","year":"2014"},{"key":"10.1016\/j.jconrel.2018.05.005_bb0025","doi-asserted-by":"crossref","first-page":"1025","DOI":"10.1093\/neuonc\/nox021","article-title":"Diffuse intrinsic pontine gliomas\u2014current management and new biologic insights. Is there a glimmer of hope?","volume":"19","author":"Cohen","year":"2017","journal-title":"Neuro-Oncology"},{"key":"10.1016\/j.jconrel.2018.05.005_bb0030","doi-asserted-by":"crossref","first-page":"752","DOI":"10.1215\/15228517-2008-043","article-title":"Motexafin gadolinium and involved field radiation therapy for intrinsic pontine glioma of childhood: a Children's Oncology Group phase I study","volume":"10","author":"Bradley","year":"2008","journal-title":"Neuro-Oncology"},{"key":"10.1016\/j.jconrel.2018.05.005_bb0035","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1038\/ng.1102","article-title":"Somatic histone H3 alterations in pediatric diffuse intrinsic pontine gliomas and non-brainstem glioblastomas","volume":"44","author":"Wu","year":"2012","journal-title":"Nat. Genet."},{"key":"10.1016\/j.jconrel.2018.05.005_bb0040","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1007\/s00401-012-0998-0","article-title":"K27M mutation in histone H3.3 defines clinically and biologically distinct subgroups of pediatric diffuse intrinsic pontine gliomas","volume":"124","author":"Khuong-Quang","year":"2012","journal-title":"Acta Neuropathol."},{"key":"10.1016\/j.jconrel.2018.05.005_bb0045","first-page":"1","article-title":"Driver mutations in histone H3.3 and chromatin remodelling genes in paediatric glioblastoma","author":"Schwartzentruber","year":"2012","journal-title":"Nature"},{"key":"10.1016\/j.jconrel.2018.05.005_bb0050","first-page":"1378","article-title":"An epigenetic therapy for diffuse intrinsic pontine gliomas","volume":"20","author":"Ramaswamy","year":"2014","journal-title":"Nat. Publ. Group"},{"key":"10.1016\/j.jconrel.2018.05.005_bb0055","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1038\/ng.2925","article-title":"Recurrent activating ACVR1 mutations in diffuse intrinsic pontine glioma","volume":"46","author":"Taylor","year":"2014","journal-title":"Nat. Genet."},{"key":"10.1016\/j.jconrel.2018.05.005_bb0060","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1007\/s00401-014-1319-6","article-title":"Histopathological spectrum of paediatric diffuse intrinsic pontine glioma: diagnostic and therapeutic implications","volume":"128","author":"Buczkowicz","year":"2014","journal-title":"Acta Neuropathol."},{"key":"10.1016\/j.jconrel.2018.05.005_bb0065","doi-asserted-by":"crossref","first-page":"444","DOI":"10.1038\/ng.2938","article-title":"The genomic landscape of diffuse intrinsic pontine glioma and pediatric non-brainstem high-grade glioma","volume":"46","author":"Wu","year":"2014","journal-title":"Nat. Genet."},{"key":"10.1016\/j.jconrel.2018.05.005_bb0070","doi-asserted-by":"crossref","first-page":"462","DOI":"10.1038\/ng.2950","article-title":"Recurrent somatic mutations in ACVR1 in pediatric midline high-grade astrocytoma","volume":"46","author":"Fontebasso","year":"2014","journal-title":"Nat. Genet."},{"key":"10.1016\/j.jconrel.2018.05.005_bb0075","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1038\/nm.3855","article-title":"Functionally defined therapeutic targets in diffuse intrinsic pontine glioma","volume":"21","author":"Grasso","year":"2015","journal-title":"Nat. Med."},{"key":"10.1016\/j.jconrel.2018.05.005_bb0080","doi-asserted-by":"crossref","first-page":"E3","DOI":"10.3171\/2011.10.FOCUS11252","article-title":"Focused ultrasound disruption of the blood-brain barrier: a new frontier for therapeutic delivery in molecular neurooncology","volume":"32","author":"Etame","year":"2012","journal-title":"Neurosurg. Focus."},{"issue":"7","key":"10.1016\/j.jconrel.2018.05.005_bb0085","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0022598","article-title":"Noninvasive, transient and selective blood-brain barrier opening in non-human Primates in vivo","volume":"6","author":"Marquet","year":"2011","journal-title":"PLoS One"},{"key":"10.1016\/j.jconrel.2018.05.005_bb0090","doi-asserted-by":"crossref","first-page":"640","DOI":"10.1148\/radiol.2202001804","article-title":"Noninvasive MR imaging\u2013guided focal opening of the blood-brain barrier in Rabbits1","volume":"220","author":"Hynynen","year":"2001","journal-title":"Radiology"},{"key":"10.1016\/j.jconrel.2018.05.005_bb0095","doi-asserted-by":"crossref","first-page":"364","DOI":"10.1007\/s12031-010-9451-9","article-title":"Mechanism of low-frequency ultrasound in opening blood\u2013tumor barrier by tight junction","volume":"43","author":"Shang","year":"2010","journal-title":"J. Mol. Neurosci."},{"key":"10.1016\/j.jconrel.2018.05.005_bb0100","doi-asserted-by":"crossref","first-page":"1399","DOI":"10.1016\/j.ultrasmedbio.2006.05.015","article-title":"Brain arterioles show more active vesicular transport of blood-borne tracer molecules than capillaries and venules after focused ultrasound-evoked opening of the blood-brain barrier","volume":"32","author":"Sheikov","year":"2006","journal-title":"Ultrasound Med. Biol."},{"key":"10.1016\/j.jconrel.2018.05.005_bb0105","doi-asserted-by":"crossref","first-page":"1093","DOI":"10.1016\/j.ultrasmedbio.2007.12.015","article-title":"Effect of focused ultrasound applied with an ultrasound contrast agent on the tight junctional integrity of the brain microvascular endothelium","volume":"34","author":"Sheikov","year":"2008","journal-title":"Ultrasound Med. Biol."},{"key":"10.1016\/j.jconrel.2018.05.005_bb0110","first-page":"1","article-title":"Blood-brain barrier closure time after controlled ultrasound-induced opening is independent of opening volume","author":"O'Reilly","year":"2017","journal-title":"J. Ultrasound Med."},{"key":"10.1016\/j.jconrel.2018.05.005_bb0115","doi-asserted-by":"crossref","first-page":"1716","DOI":"10.1016\/j.ultrasmedbio.2012.04.015","article-title":"Improved anti-tumor effect of liposomal doxorubicin after targeted blood-brain barrier disruption by MRI-guided focused ultrasound in rat glioma","volume":"38","author":"Treat","year":"2012","journal-title":"Ultrasound Med. Biol."},{"key":"10.1016\/j.jconrel.2018.05.005_bb0120","article-title":"Focused ultrasound-induced blood\u2013brain barrier opening to enhance Temozolomide delivery for glioblastoma treatment: a preclinical study","volume":"8","author":"Wei","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.jconrel.2018.05.005_bb0125","doi-asserted-by":"crossref","first-page":"1892","DOI":"10.1158\/0008-5472.CAN-12-2609","article-title":"Focused ultrasound delivers targeted immune cells to metastatic brain tumors","volume":"73","author":"Alkins","year":"2013","journal-title":"Cancer Res."},{"key":"10.1016\/j.jconrel.2018.05.005_bb0130","doi-asserted-by":"crossref","first-page":"11719","DOI":"10.1073\/pnas.0604318103","article-title":"Noninvasive localized delivery of Herceptin to the mouse brain by MRI-guided focused ultrasound-induced blood-brain barrier disruption","volume":"103","author":"Kinoshita","year":"2006","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.jconrel.2018.05.005_bb0135","doi-asserted-by":"crossref","first-page":"1219","DOI":"10.1088\/0031-9155\/47\/8\/301","article-title":"A non-invasive method for focusing ultrasound through the human skull","volume":"47","author":"Clement","year":"2002","journal-title":"Phys. Med. Biol."},{"key":"10.1016\/j.jconrel.2018.05.005_bb0140","article-title":"Focused ultrasound delivery of Raman nanoparticles across the blood-brain barrier: potential for targeting experimental brain tumors","volume":"10","author":"Diaz","year":"2014","journal-title":"Nanomedicine"},{"key":"10.1016\/j.jconrel.2018.05.005_bb0145","doi-asserted-by":"crossref","first-page":"2286","DOI":"10.1109\/TBME.2010.2050483","article-title":"A PVDF receiver for ultrasound monitoring of transcranial focused ultrasound therapy","volume":"57","author":"O'Reilly","year":"2011","journal-title":"IEEE Trans. Biomed. Eng."},{"key":"10.1016\/j.jconrel.2018.05.005_bb0150","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1148\/radiol.11111417","article-title":"Blood-brain barrier: real-time feedback-controlled focused ultrasound disruption by using an acoustic emissions\u2013based controller","volume":"263","author":"O'Reilly","year":"2012","journal-title":"Radiology"},{"key":"10.1016\/j.jconrel.2018.05.005_bb0155","first-page":"1","article-title":"Characterization of different microbubbles in assisting focused ultrasound-induced blood-brain barrier opening","author":"Wu","year":"2017","journal-title":"Sci. Rep."},{"key":"10.1016\/j.jconrel.2018.05.005_bb0160","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0061512","article-title":"In vitro drug response and efflux transporters associated with drug resistance in pediatric high grade glioma and diffuse intrinsic pontine glioma","volume":"8","author":"Veringa","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.jconrel.2018.05.005_bb0165","doi-asserted-by":"crossref","first-page":"1252","DOI":"10.1002\/bmc.1054","article-title":"Improved HPLC method for doxorubicin quantification in rat plasma to study the pharmacokinetics of micelle-encapsulated and liposome-encapsulated doxorubicin formulations","volume":"22","author":"Wei","year":"2008","journal-title":"Biomed. Chromatogr."},{"key":"10.1016\/j.jconrel.2018.05.005_bb0170","series-title":"Quantification of doxorubicin and Metabolites in Rat Plasma and Small Volume Tissue Samples by Liquid Chromatography\/Electrospray Tandem Mass Spectroscopy","first-page":"141","volume":"808","author":"Arnold","year":"2004"},{"key":"10.1016\/j.jconrel.2018.05.005_bb0175","doi-asserted-by":"crossref","first-page":"1930","DOI":"10.1016\/j.ultrasmedbio.2011.08.001","article-title":"Ultrasound insertion loss of rat parietal bone appears to be proportional to animal mass at submegahertz frequencies","volume":"37","author":"O'Reilly","year":"2011","journal-title":"Ultrasound Med. Biol."},{"key":"10.1016\/j.jconrel.2018.05.005_bb0180","doi-asserted-by":"crossref","first-page":"1527","DOI":"10.1016\/j.ultrasmedbio.2005.07.010","article-title":"MRI-guided targeted blood-brain barrier disruption with focused ultrasound: histological findings in rabbits","volume":"31","author":"McDannold","year":"2005","journal-title":"Ultrasound Med. Biol."},{"key":"10.1016\/j.jconrel.2018.05.005_bb0185","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1007\/BF00695604","article-title":"Relationship between specific gravity, water content, and serum protein extravasation in various types of vasogenic brain edema","volume":"64","author":"Bothe","year":"1984","journal-title":"Acta Neuropathol."},{"key":"10.1016\/j.jconrel.2018.05.005_bb0190","doi-asserted-by":"crossref","first-page":"679","DOI":"10.1016\/S0026-895X(24)26466-X","article-title":"New advances in the transport of doxorubicin through the blood-brain barrier by a peptide vector-mediated strategy","volume":"57","author":"Rousselle","year":"2000","journal-title":"Mol. Pharmacol."},{"key":"10.1016\/j.jconrel.2018.05.005_bb0195","doi-asserted-by":"crossref","first-page":"1541","DOI":"10.1016\/0006-2952(95)00082-B","article-title":"In vivo and in vitro evidence for ATP-dependency of P-glycoprotein-mediated efflux of doxorubicin at the blood-brain barrier","volume":"49","author":"Ohnishi","year":"1995","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.jconrel.2018.05.005_bb0200","doi-asserted-by":"crossref","unstructured":"M.I. Vanan, D.D. Eisenstat, DIPG in children \u2013 what can we learn from the past? Front. Oncologia 5 (2015) v1\u201317. doi:https:\/\/doi.org\/10.3389\/fonc.2015.00237.","DOI":"10.3389\/fonc.2015.00237"},{"key":"10.1016\/j.jconrel.2018.05.005_bb0205","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1007\/s13311-014-0281-2","article-title":"Intracranial applications of magnetic resonance-guided focused ultrasound","volume":"11","author":"Lipsman","year":"2014","journal-title":"Neurotherapeutics"},{"key":"10.1016\/j.jconrel.2018.05.005_bb0210","doi-asserted-by":"crossref","first-page":"2010","DOI":"10.1200\/JCO.2017.35.15_suppl.2010","article-title":"A phase I study of convection enhanced delivery (CED) of 124I-8H9 radio-labeled monoclonal antibody in children with diffuse intrinsic pontine glioma (DIPG)","volume":"35","author":"Souweidane","year":"2017","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.jconrel.2018.05.005_bb0215","doi-asserted-by":"crossref","first-page":"289","DOI":"10.3171\/2012.10.PEDS12142","article-title":"Convection-enhanced delivery of topotecan into diffuse intrinsic brainstem tumors in children","volume":"11","author":"Anderson","year":"2013","journal-title":"J. Neurosurg. Pediatr."},{"key":"10.1016\/j.jconrel.2018.05.005_bb0220","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/j.jneumeth.2015.11.008","article-title":"Chronic, intermittent convection-enhanced delivery devices","volume":"259","author":"Lewis","year":"2016","journal-title":"J. Neurosci. Methods"},{"key":"10.1016\/j.jconrel.2018.05.005_bb0225","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1227\/00006123-198203000-00009","article-title":"Intracerebral chemotherapy: chronic microinfusion of cisplatin","volume":"10","author":"Kroin","year":"1982","journal-title":"Neurosurgery"},{"key":"10.1016\/j.jconrel.2018.05.005_bb0230","doi-asserted-by":"crossref","first-page":"3652","DOI":"10.1158\/0008-5472.CAN-12-0128","article-title":"Temporary disruption of the blood-brain barrier by use of ultrasound and microbubbles: safety and efficacy evaluation in rhesus macaques","volume":"72","author":"McDannold","year":"2012","journal-title":"Cancer Res."},{"key":"10.1016\/j.jconrel.2018.05.005_bb0235","series-title":"MRI-Guided Focused Ultrasound Surgery","author":"Jolesz","year":"2007"},{"key":"10.1016\/j.jconrel.2018.05.005_bb0240","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1586\/14737175.2015.1028369","article-title":"Focused ultrasound-mediated drug delivery through the blood\u2013brain barrier","volume":"15","author":"Burgess","year":"2015","journal-title":"Expert. Rev. Neurother."},{"key":"10.1016\/j.jconrel.2018.05.005_bb0245","doi-asserted-by":"crossref","first-page":"5987","DOI":"10.1088\/0031-9155\/59\/20\/5987","article-title":"Modeling localized delivery of doxorubicin to the brain following focused ultrasound enhanced blood-brain barrier permeability","volume":"59","author":"Nhan","year":"2014","journal-title":"Phys. Med. Biol."},{"key":"10.1016\/j.jconrel.2018.05.005_bb0250","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1016\/j.nlm.2004.01.001","article-title":"Short and long-term motor skill learning in an accelerated rotarod training paradigm","volume":"81","author":"Buitrago","year":"2004","journal-title":"Neurobiol. Learn. Mem."},{"key":"10.1016\/j.jconrel.2018.05.005_bb0255","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1148\/radiol.2016152154","article-title":"Opening the blood-brain barrier with MR imaging\u2013guided focused ultrasound: preclinical testing on a trans\u2013human skull porcine model","volume":"282","author":"Huang","year":"2017","journal-title":"Radiology"},{"key":"10.1016\/j.jconrel.2018.05.005_bb0260","doi-asserted-by":"crossref","first-page":"E75","DOI":"10.1073\/pnas.1614777114","article-title":"Disrupting the blood\u2013brain barrier by focused ultrasound induces sterile inflammation","volume":"114","author":"Kovacs","year":"2017","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.jconrel.2018.05.005_bb0265","doi-asserted-by":"crossref","first-page":"3989","DOI":"10.7150\/thno.21630","article-title":"Acute inflammatory response following increased blood-brain barrier permeability induced by focused ultrasound is dependent on microbubble dose","volume":"7","author":"McMahon","year":"2017","journal-title":"Theranostics"},{"key":"10.1016\/j.jconrel.2018.05.005_bb0270","first-page":"2295","article-title":"Comparative pharmacokinetics of free doxorubicin and doxorubicin entrapped in Cardiolipin liposomes","volume":"46","author":"Rahman","year":"1986","journal-title":"Cancer Res."},{"key":"10.1016\/j.jconrel.2018.05.005_bb0275","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/j.jconrel.2016.10.011","article-title":"Evaluation of permeability, doxorubicin delivery, and drug retention in a rat brain tumor model after ultrasound-induced blood-tumor barrier disruption","volume":"250","author":"Park","year":"2017","journal-title":"J. Control. Release"}],"container-title":["Journal of Controlled Release"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0168365918302621?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0168365918302621?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,29]],"date-time":"2025-09-29T15:33:52Z","timestamp":1759160032000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0168365918302621"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,7]]},"references-count":55,"alternative-id":["S0168365918302621"],"URL":"https:\/\/doi.org\/10.1016\/j.jconrel.2018.05.005","relation":{},"ISSN":["0168-3659"],"issn-type":[{"value":"0168-3659","type":"print"}],"subject":[],"published":{"date-parts":[[2018,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Brainstem blood brain barrier disruption using focused ultrasound: A demonstration of feasibility and enhanced doxorubicin delivery","name":"articletitle","label":"Article Title"},{"value":"Journal of Controlled Release","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jconrel.2018.05.005","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}